Sumitomo Chemical India Ltd

Sumitomo Chemi. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sumitomo Chemical India Ltd

₹ 406 -0.34%
26 Apr 10:46 a.m.
sumichem.co.in BSE: 542920 NSE : SUMICHEM
About

Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world.[1] [2]

Key Points

Products
The Company has a presence in all the product segments - insecticides, weedicides, fungicides, fumigants and rodenticides, plant growth nutrition products, bio-rationals, and plant growth regulators. The Company is known for domestic marketing of proprietary products of its Japanese parent – Sumitomo Chemical Company, Limited in agrochemicals, animal nutrition, and environmental health business segments. [1]

The products comprise conventional chemistry sourced from the parent company, SCC, and biological products sourced from a USA-based subsidiary, Valent Biosciences LLC, a leader in producing a range of naturally occurring, environmentally compatible pesticides and plant growth regulators, for over 40 years. [2]

Website BSE NSE
  • Market Cap ₹ 20,248 Cr.
  • Current Price ₹ 406
  • High / Low ₹ 455 / 336
  • Stock P/E 60.9
  • Book Value ₹ 50.6
  • Dividend Yield 0.29 %
  • ROCE 29.1 %
  • ROE 22.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 27.3% CAGR over last 5 years

Cons

  • Stock is trading at 8.04 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
561 534 782 910 707 665 986 1,121 753 652 724 903 542
483 463 632 696 581 556 798 843 633 571 644 716 476
Operating Profit 78 71 150 215 127 109 188 278 120 81 81 188 66
OPM % 14% 13% 19% 24% 18% 16% 19% 25% 16% 12% 11% 21% 12%
5 5 5 8 6 7 5 11 13 16 18 25 27
Interest 1 1 2 2 2 1 1 1 1 1 1 1 1
Depreciation 11 13 11 11 11 11 11 15 11 14 14 16 16
Profit before tax 71 61 142 210 120 104 180 272 121 82 83 196 75
Tax % 24% 12% 26% 26% 26% 28% 23% 26% 25% 12% 26% 27% 27%
54 54 106 154 89 75 138 201 90 72 62 143 55
EPS in Rs 1.08 1.08 2.12 3.09 1.78 1.50 2.77 4.04 1.81 1.45 1.24 2.87 1.10
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
1,913 2,228 2,425 2,645 3,061 3,511 2,821
1,693 1,938 2,090 2,157 2,459 2,850 2,406
Operating Profit 220 291 335 488 602 661 415
OPM % 11% 13% 14% 18% 20% 19% 15%
30 1 -20 19 27 51 85
Interest 5 4 7 7 8 6 5
Depreciation 24 28 41 47 45 52 59
Profit before tax 221 260 267 453 576 654 436
Tax % 34% 36% 23% 24% 26% 23%
145 166 205 345 424 502 332
EPS in Rs 4.10 6.92 8.49 10.06 6.66
Dividend Payout % 0% 38% 18% 12% 12% 12%
Compounded Sales Growth
10 Years: %
5 Years: 13%
3 Years: 13%
TTM: -20%
Compounded Profit Growth
10 Years: %
5 Years: 27%
3 Years: 29%
TTM: -34%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 10%
1 Year: 1%
Return on Equity
10 Years: %
5 Years: 22%
3 Years: 24%
Last Year: 23%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 275 275 499 499 499 499 499
Reserves 679 774 723 1,042 1,428 1,883 2,027
10 20 36 33 38 34 29
694 792 849 1,098 1,045 953 973
Total Liabilities 1,658 1,860 2,106 2,672 3,010 3,369 3,528
267 279 319 309 390 430 501
CWIP 9 8 10 14 35 71 23
Investments 0 0 86 290 356 239 587
1,383 1,572 1,690 2,058 2,228 2,629 2,417
Total Assets 1,658 1,860 2,106 2,672 3,010 3,369 3,528

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
47 78 221 425 222 389
-40 -35 -118 -283 -290 -327
7 -65 -61 -47 -63 -73
Net Cash Flow 15 -23 42 96 -131 -10

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 105 110 128 117 101 98
Inventory Days 203 193 146 185 198 157
Days Payable 176 136 122 145 109 87
Cash Conversion Cycle 133 166 152 157 189 169
Working Capital Days 116 119 112 98 129 138
ROCE % 27% 26% 32% 33% 29%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00% 75.00%
1.22% 1.32% 1.36% 1.69% 1.90% 2.05% 2.44% 2.40% 2.51% 2.58% 2.61% 2.74%
6.57% 6.13% 6.17% 6.36% 6.70% 6.39% 5.52% 5.50% 5.50% 6.06% 6.02% 6.63%
17.21% 17.55% 17.47% 16.95% 16.40% 16.54% 17.02% 17.09% 16.96% 16.33% 16.35% 15.61%
No. of Shareholders 78,6511,19,5611,50,5891,39,6011,33,6581,46,0631,44,0181,42,5961,56,1361,47,9071,45,0831,48,764

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls